| 000 | 02587 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250516233224.0 | ||
| 264 | 0 | _c20150127 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(14)70391-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Joyce F | |
| 245 | 0 | 0 |
_aCombination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cOct 2014 |
||
| 300 |
_a1207-14 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCarcinoma, Ovarian Epithelial |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xdrug therapy |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhthalazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBarry, William T | |
| 700 | 1 | _aBirrer, Michael | |
| 700 | 1 | _aLee, Jung-Min | |
| 700 | 1 | _aBuckanovich, Ronald J | |
| 700 | 1 | _aFleming, Gini F | |
| 700 | 1 | _aRimel, Bj | |
| 700 | 1 | _aBuss, Mary K | |
| 700 | 1 | _aNattam, Sreenivasa | |
| 700 | 1 | _aHurteau, Jean | |
| 700 | 1 | _aLuo, Weixiu | |
| 700 | 1 | _aQuy, Philippa | |
| 700 | 1 | _aWhalen, Christin | |
| 700 | 1 | _aObermayer, Lisa | |
| 700 | 1 | _aLee, Hang | |
| 700 | 1 | _aWiner, Eric P | |
| 700 | 1 | _aKohn, Elise C | |
| 700 | 1 | _aIvy, S Percy | |
| 700 | 1 | _aMatulonis, Ursula A | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 15 _gno. 11 _gp. 1207-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(14)70391-2 _zAvailable from publisher's website |
| 999 |
_c24188531 _d24188531 |
||